These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8632489)

  • 21. A Fusion Protein of RGD4C and β-Lactamase Has a Favorable Targeting Effect in Its Use in Antibody Directed Enzyme Prodrug Therapy.
    Wang H; Zhou XL; Long W; Liu JJ; Fan FY
    Int J Mol Sci; 2015 Apr; 16(5):9625-34. PubMed ID: 25927583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-directed enzyme prodrug therapy (ADEPT) for cancer.
    Bagshawe KD
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1421-31. PubMed ID: 17069527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-directed enzyme prodrug therapy (ADEPT): a review.
    Springer CJ; Niculescu-Duvaz I
    Adv Drug Deliv Rev; 1997 Jul; 26(2-3):151-172. PubMed ID: 10837540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.
    Hao XK; Liu JY; Yue QH; Wu GJ; Bai YJ; Yin Y
    Prostate; 2006 Jun; 66(8):858-66. PubMed ID: 16491483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer.
    Connors TA
    Gene Ther; 1995 Dec; 2(10):702-9. PubMed ID: 8750009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody directed enzyme prodrug therapy (ADEPT) and related approaches for anticancer therapy.
    Jung M
    Mini Rev Med Chem; 2001 Nov; 1(4):399-407. PubMed ID: 12369965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-directed enzyme prodrug therapy (ADEPT) for treatment of major solid tumour disease.
    Blakey DC; Burke PJ; Davies DH; Dowell RI; Melton RG; Springer CJ; Wright AF
    Biochem Soc Trans; 1995 Nov; 23(4):1047-50. PubMed ID: 8654679
    [No Abstract]   [Full Text] [Related]  

  • 28. Prodrugs in cancer chemotherapy.
    Connors TA; Knox RJ
    Stem Cells; 1995 Sep; 13(5):501-11. PubMed ID: 8528099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody Directed Enzyme Prodrug Therapy (ADEPT): Trials and tribulations.
    Sharma SK; Bagshawe KD
    Adv Drug Deliv Rev; 2017 Sep; 118():2-7. PubMed ID: 28916498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy.
    Sharma SK; Pedley RB; Bhatia J; Boxer GM; El-Emir E; Qureshi U; Tolner B; Lowe H; Michael NP; Minton N; Begent RH; Chester KA
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):814-25. PubMed ID: 15701872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspects.
    Bagshawe KD; Sharma SK; Springer CJ; Rogers GT
    Ann Oncol; 1994 Dec; 5(10):879-91. PubMed ID: 7696159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, construction, and in vitro analysis of A33scFv::CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer.
    Coelho V; Dernedde J; Petrausch U; Panjideh H; Fuchs H; Menzel C; Dübel S; Keilholz U; Thiel E; Deckert PM
    Int J Oncol; 2007 Oct; 31(4):951-7. PubMed ID: 17786329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging.
    Sekar TV; Foygel K; Willmann JK; Paulmurugan R
    Gene Ther; 2013 May; 20(5):529-37. PubMed ID: 22914496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT).
    Mayer A; Sharma SK; Tolner B; Minton NP; Purdy D; Amlot P; Tharakan G; Begent RH; Chester KA
    Br J Cancer; 2004 Jun; 90(12):2402-10. PubMed ID: 15162148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of "biobetter" glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment.
    AlQahtani AD; Al-Mansoori L; Bashraheel SS; Rashidi FB; Al-Yafei A; Elsinga P; Domling A; Goda SK
    Eur J Pharm Sci; 2019 Jan; 127():79-91. PubMed ID: 30343151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibody.
    Syrigos KN; Rowlinson-Busza G; Epenetos AA
    Int J Cancer; 1998 Dec; 78(6):712-9. PubMed ID: 9833764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy.
    Chen BM; Cheng TL; Tzou SC; Roffler SR
    Int J Cancer; 2001 Dec; 94(6):850-8. PubMed ID: 11745488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody conjugate therapeutics: challenges and potential.
    Teicher BA; Chari RV
    Clin Cancer Res; 2011 Oct; 17(20):6389-97. PubMed ID: 22003066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT).
    Niculescu-Duvaz I; Friedlos F; Niculescu-Duvaz D; Davies L; Springer CJ
    Anticancer Drug Des; 1999 Dec; 14(6):517-38. PubMed ID: 10834273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery.
    Asai T; Trinh R; Ng PP; Penichet ML; Wims LA; Morrison SL
    Biomol Eng; 2005 Feb; 21(6):145-55. PubMed ID: 15748688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.